Jane Street’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-18,252
| Closed | -$118K | – | 6666 |
|
2025
Q1 | $118K | Sell |
18,252
-124,825
| -87% | -$809K | ﹤0.01% | 5147 |
|
2024
Q4 | $1.05M | Buy |
143,077
+12,730
| +10% | +$93.4K | ﹤0.01% | 2885 |
|
2024
Q3 | $976K | Sell |
130,347
-62,104
| -32% | -$465K | ﹤0.01% | 3432 |
|
2024
Q2 | $1.71M | Buy |
192,451
+91,941
| +91% | +$818K | ﹤0.01% | 2939 |
|
2024
Q1 | $1.02M | Buy |
100,510
+27,204
| +37% | +$276K | ﹤0.01% | 3181 |
|
2023
Q4 | $737K | Buy |
73,306
+44,845
| +158% | +$451K | ﹤0.01% | 3684 |
|
2023
Q3 | $267K | Sell |
28,461
-111,924
| -80% | -$1.05M | ﹤0.01% | 4169 |
|
2023
Q2 | $3.44M | Buy |
140,385
+101,410
| +260% | +$2.49M | ﹤0.01% | 1840 |
|
2023
Q1 | $907K | Buy |
38,975
+28,357
| +267% | +$660K | ﹤0.01% | 2933 |
|
2022
Q4 | $269K | Sell |
10,618
-61,994
| -85% | -$1.57M | ﹤0.01% | 4081 |
|
2022
Q3 | $1.4M | Buy |
72,612
+64,509
| +796% | +$1.24M | ﹤0.01% | 2442 |
|
2022
Q2 | $206K | Sell |
8,103
-122,518
| -94% | -$3.11M | ﹤0.01% | 4423 |
|
2022
Q1 | $3.36M | Buy |
130,621
+3,663
| +3% | +$94.2K | ﹤0.01% | 1576 |
|
2021
Q4 | $5.32M | Buy |
126,958
+91,287
| +256% | +$3.82M | ﹤0.01% | 1035 |
|
2021
Q3 | $1.55M | Buy |
35,671
+15,926
| +81% | +$693K | ﹤0.01% | 2139 |
|
2021
Q2 | $933K | Buy |
+19,745
| New | +$933K | ﹤0.01% | 2689 |
|
2021
Q1 | – | Sell |
-26,579
| Closed | -$712K | – | 5423 |
|
2020
Q4 | $712K | Sell |
26,579
-3,945
| -13% | -$106K | ﹤0.01% | 2423 |
|
2020
Q3 | $1.05M | Sell |
30,524
-25,102
| -45% | -$862K | ﹤0.01% | 1755 |
|
2020
Q2 | $2.28M | Buy |
+55,626
| New | +$2.28M | ﹤0.01% | 1231 |
|